leisure time -WSS

leisure time

author：Wikipedia 2025-09-29 21:26:57 - browse：7117

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

I have one more, admittedly braggy thing to say about last week’s STAT Breakthrough Summit West in San Francisco. Of course we curated an incredible roster of influential industry leaders to speak on stage. That’s what STAT does. But just as remarkable were the health care and health tech A-Listers who just showed up as summit attendees to listen and learn from their peers — like 23AndMe’s Anne Wojcicki. Please join us in San Francisco next year, or better yet, register for our next summit in Boston, Oct. 16-17.

I’m back in Boston from San Francisco, but flying out again next week, this time to Chicago for the annual meeting of the American Society of Clinical Oncology. How can we be knocking on June, already?

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Mayo Clinic plans $5B tech

WSS

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Diagnostic tests are hitting their mathematical limits

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Organ aging and disease risk measured by new blood test

BIO selects John Crowley as new CEO

Takeda, Janssen join wearable maker to measure scratching

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Bright Health sells Medicare Advantage business to Molina

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

As demand for Covid shots wanes, Moderna seeks its next success

Fetal surgery at risk from Dobbs and new abortion restrictions

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Rep. Raul Ruiz on the physician shortage and more

Malaria cases in Florida and Texas: Here’s what you need to know

Organ aging and disease risk measured by new blood test

In age of alternative facts, a scholarly course on calling out crap

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

leisure time

J&J to emphasize cancer drugs, stop much of its vaccine research

Will the market for weight loss drugs really reach $100 billion?

30 years of 'Listening to Prozac'

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Flagship Pioneering launches a new biotech in two countries

CDC director unscathed in first congressional testimony

hotspot

focus

focus

focus